N
Nektar Therapeutics D
D
NKTR
27.300
USD
0.56
(2.09%)
مغلق
حجم التداول
49,586
الربح لكل سهم
-11
العائد الربحي
-
P/E
-3
حجم السوق
519,207,043
الأخبار المقالات
العنوان: Nektar Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.